We then conducted a meta-analysis on the relationship of MALAT1 expression and the overall survival (OS) of patients with RCC; we found that heterogeneity was not significant (I2 = 0.0%, p = 0.591). Here, MALAT1 is linked to renal cell adenocarcinoma.